| Study Period | 2019 - 2032 |
| Market Size in 2025 | USD 10.3 Billion |
| Market Size in 2026 | USD 11.4 Billion |
| Market Size by 2032 | USD 22.3 Billion |
| Projected CAGR | 11.7% |
| Largest Region | North America |
| Fastest-Growing Region | Asia-Pacific |
| Market Structure | Fragmented |
Explore the market potential with our data-driven report
The orthopedic contract manufacturing market size will be an estimated USD 10.3 billion for 2025, and it will grow by 11.7% during 2026–2032, to reach USD 22.3 billion by 2032.
The market expansion is primarily driven by the rising prevalence of musculoskeletal disorders, increasing adoption of minimally invasive surgical techniques, and growing demand for specialized precision manufacturing services across the orthopedic industry.
The surging geriatric population is a key factor contributing to the rising demand for orthopedic implants and devices. Older populations experience higher rates of musculoskeletal conditions requiring surgical interventions. Approximately 1.71 billion people globally live with musculoskeletal conditions, including lower back pain, neck pain, fractures, osteoarthritis, amputation, and other injuries. This massive disease burden drives consistent demand for orthopedic implants and instruments, compelling original equipment manufacturers to outsource production to specialized contract manufacturers who offer precision engineering, regulatory compliance, and cost-effective solutions.
The shift toward minimally invasive surgeries is creating substantial opportunities for contract manufacturers. These advanced surgical techniques demand highly specialized instruments and implants manufactured with extreme precision. Contract manufacturers provide critical capabilities in CNC machining, additive manufacturing, and advanced finishing processes that enable the production of these complex devices while allowing OEMs to focus on innovation and market expansion. This makes contract manufacturers an increasingly important part of the orthopedic value chain, bridging the gap between design innovation and large-scale, compliant production.
The implants category holds the largest market share, of 65%, in 2025, driven by the rising demand for joint reconstruction implants, spinal devices, and trauma fixation products across global healthcare systems. The increasing prevalence of musculoskeletal disorders and the growing number of joint replacement surgeries create sustained demand for high-quality implants manufactured with precision and reliability. Contract manufacturers provide specialized capabilities in forging, casting, machining, and finishing processes that are essential for producing complex implant geometries with biocompatible materials.
The instruments category will have the highest CAGR, of 11.9%, owing to the increasing complexity of orthopedic surgical procedures and rising demand for precision-engineered surgical tools. Both reusable and single-use instruments require specialized manufacturing processes, including precision machining, laser cutting, and advanced coating applications. Contract manufacturers offer comprehensive instrument manufacturing services that enable OEMs to optimize costs while maintaining the highest quality standards. The growing adoption of robotic-assisted surgeries and sensor-enabled instruments is driving innovation in instrument manufacturing, underscoring the critical role of contract manufacturers in enabling innovation, precision, and scalability across the orthopedic product landscape.
The product types analyzed in this report are:
The class II category holds the largest market share, of 60%, in 2025, due to the substantial volume of orthopedic devices falling under this FDA classification. Class II medical devices represent the majority of orthopedic implants and instruments used in common procedures such as joint replacements, spinal surgeries, and trauma fixation. These devices require moderate regulatory oversight and must demonstrate substantial equivalence to existing marketed devices.
Contract manufacturers specializing in Class II devices provide comprehensive services, including design support, manufacturing process validation, quality management systems, and regulatory compliance assistance. The growing demand for joint reconstruction devices, particularly hip and knee implants, drives consistent production volumes in the Class II category.
The class III category will have the highest CAGR during the forecast period, owing to increasing innovation in advanced orthopedic technologies, including novel spinal implants, bone healing devices, and next-generation joint replacement systems. Class III devices require more extensive regulatory review and clinical data, creating opportunities for contract manufacturers who offer specialized regulatory expertise and advanced manufacturing capabilities.
The classes of devices analyzed in this report are:
The hospitals category holds the largest market share, of 70%, in 2025. Hospitals represent the primary procurement and utilization centers for orthopedic implants and devices, performing the vast majority of orthopedic surgical procedures globally. The high volume of joint replacements, trauma surgeries, and spinal procedures conducted in hospital settings drives substantial demand for contract-manufactured orthopedic products.
Hospitals typically maintain established relationships with multiple orthopedic device manufacturers who, in turn, rely heavily on contract manufacturers for production. The trend toward hospital consolidation and group purchasing organizations creates opportunities for contract manufacturers to secure large-volume supply agreements. Hospitals increasingly prioritize device quality, regulatory compliance, and cost-effectiveness, all of which are core competencies of specialized contract manufacturers.
The outpatient facilities category will have the highest CAGR, of 12.0%, owing to the accelerating shift toward same-day discharge for joint replacement surgeries and other orthopedic procedures. Ambulatory surgery centers are experiencing rapid growth due to their cost advantages, patient convenience, and focus on elective procedures. This trend is driving demand for specialized orthopedic devices tailored to outpatient settings, including pre-configured surgical kits, single-use instruments, and standardized implant systems, to enable efficient surgical workflows. Contract manufacturers are adapting their service offerings to meet the specific needs of the outpatient market segment.
The end users analyzed in this report are:
Drive strategic growth with comprehensive market analysis
North America holds the largest market share, of 40%, in 2025. This dominance is primarily attributed to the presence of a well-established medical device industry, advanced healthcare infrastructure, and high procedural volumes for orthopedic surgeries.
The rapid expansion of ambulatory surgery centers across North America is transforming the region’s orthopedic device landscape. The Centers for Medicare & Medicaid Services recorded an 8% rise in orthopedic procedure volumes, reflecting increased surgical activity that drives demand for contract manufacturing services.
North American contract manufacturers are investing heavily in advanced technologies, including additive manufacturing, automation, and digital quality systems. The region's regulatory environment, while stringent, is well-established and predictable, enabling efficient product development and commercialization. Strong intellectual property protections and access to skilled engineering talent further strengthen North America's position as a leading market for orthopedic contract manufacturing.
The U.S. represents the single largest market for orthopedic contract manufacturing, driven by substantial healthcare spending and strong demand for innovative orthopedic solutions. This regulatory activity demonstrates the robust innovation pipeline and increasing reliance on contract manufacturers to bring new products to market. The region benefits from the presence of major orthopedic device manufacturers, including Stryker, Zimmer Biomet, and DePuy Synthes, which maintain extensive outsourcing relationships with contract manufacturers.
Asia-Pacific will have the highest CAGR, of 11.8%, during the forecast period. The growth of the market can be mainly attributed to rapidly expanding healthcare infrastructure, cost-competitive manufacturing capabilities, and increasing demand for orthopedic procedures across the region. China, India, and Japan are experiencing significant growth in orthopedic surgery volumes driven by aging populations and rising healthcare expenditure. The region offers substantial cost advantages for contract manufacturing while maintaining high quality standards. Many global orthopedic device manufacturers are establishing or expanding their manufacturing footprint in Asia-Pacific to optimize production costs and access growing local markets.
Moreover, Government initiatives supporting medical device manufacturing, favorable regulatory reforms, and investments in healthcare infrastructure are accelerating market growth. For instance, India’s National Medical Devices Policy 2023 and China’s ‘Made in China 2025’ initiative are encouraging domestic orthopedic device manufacturing under supportive FDI frameworks. Furthermore, rising awareness of advanced surgical options and improving insurance coverage are expanding the patient pool for orthopedic procedures. These demographic and economic trends position Asia-Pacific as the highest-growth region for orthopedic contract manufacturing over the forecast period.
The regions and countries analyzed are as follows:
The market is fragmented due to the presence of numerous specialized contract manufacturers, ranging from large multinational companies to smaller regional players. The industry is characterized by intense competition, with manufacturers differentiating themselves through technical capabilities, quality systems, regulatory expertise, and customer service. Companies offering comprehensive end-to-end services from design support through final packaging and sterilization maintain competitive advantages. Additionally, regional players often serve localized OEMs or cater to specific regulatory markets, contributing to the decentralized nature of the industry. The limited standardization in orthopedic manufacturing processes and regulatory variations across regions also contribute to the persistence of a fragmented competitive landscape.
Want a report tailored exactly to your business need?
Request CustomizationLeading companies across industries trust us to deliver data-driven insights and innovative solutions for their most critical decisions. From data-driven strategies to actionable insights, we empower the decision-makers who shape industries and define the future. From Fortune 500 companies to innovative startups, we are proud to partner with organisations that drive progress in their industries.
Working with P&S Intelligence and their team was an absolute pleasure – their awareness of timelines and commitment to value greatly contributed to our project's success. Eagerly anticipating future collaborations.
McKinsey & Company
India
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws
Customize the Report to Align with Your Business Objectives
Request the Free Sample Pages